Phenotypic impact of FXN gene splicing reprogramming in Friedreich Ataxia cells and mice

23 ore fa

Italia Italian Ministry of Education, University and Research Tempo pieno 28.000 € - 36.000 € Contratto

Organisation/Company Università di Trento Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 25 Nov 2026 - 12:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No



Scopra di più sui compiti quotidiani, le responsabilità generali e l'esperienza richiesta per questa opportunità scorrendo subito verso il basso.
Offer Description

Friedreich Ataxia (FRDA) is a rare, progressive neurodegenerative disorder caused by a GAA trinucleotide repeat expansion in the first intron of the FXN gene, resulting in reduced expression of frataxin, a mitochondrial protein essential for iron-sulfur cluster biogenesis and cellular energy metabolism. Frataxin deficiency leads to mitochondrial dysfunction and progressive neurological and cardiac manifestations, with cardiomyopathy representing a major cause of morbidity and mortality. The research program aims to investigate the molecular and functional consequences of a novel therapeutic strategy designed to increase endogenous frataxin expression through reprogramming of FXN pre-mRNA alternative splicing. [...]



  • AFRICA
  • EUROPE
  • OCEANIA
  • NORTH AMERICA
  • SOUTH AMERICA
  • ASIA
  • OTHER
  • E. xbvzest U.
  • CHINA (MAINLAND)
  • CHINA (HONG KONG)

Eligibility of fellows: country/ies of residence:



  • AFRICA
  • EUROPE
  • OCEANIA
  • NORTH AMERICA
  • SOUTH AMERICA
  • ASIA
  • OTHER
  • E.U.
  • CHINA (MAINLAND)
  • CHINA (HONG KONG)

Eligibility of fellows: nationality/ies:



  • Contact phone: 7 - 1914 - 1969 - 3547